PAVmed to Host Q3 2026 Business Update Conference Call on November 13

PAVmed Announces Q3 2026 Conference Call

PAVmed Inc. (Nasdaq: PAVM), a leading diversified medical technology company, is set to hold a business update conference call on November 13, 2026, at 8:30 AM ET. This conference call will be an important event for investors and stakeholders, as the company's Chairman and CEO, Dr. Lishan Aklog, will provide updates on its operations and strategic growth initiatives. Additionally, the President and CFO, Dennis McGrath, will delve into the financial performance for the third quarter of 2026.

The conference call is poised to deliver insights into the company's progress within its comprehensive portfolio that spans medical devices, diagnostic tools, and digital health solutions. Interest in PAVmed's innovative approaches continues to grow, especially as the healthcare sector increasingly embraces advanced technologies.

During the call, Dr. Aklog will outline the significant strides PAVmed has made in various key areas. One notable aspect will be the focus on their subsidiary, Lucid Diagnostics, which has been pivotal in the early detection of precancerous conditions. The EsoGuard® DNA test and EsoCheck® Cell Collection Device are groundbreaking solutions offered by Lucid that allow healthcare providers to mitigate risks associated with esophageal cancer, a condition that remains notoriously difficult to diagnose at early stages. This focus on early detection is a vital part of PAVmed’s strategy to improve patient outcomes and reduce healthcare costs.

Moreover, the audience can expect discussions around Veris Health Inc., another subsidiary that aims to enhance personalized cancer care. Through the development of continuous patient monitoring solutions integrated with advanced sensor technology, Veris Health is making significant contributions to improving treatment efficacy for cancer patients.

Listeners interested in the conference call can access it via the investor relations section of PAVmed's official website at pavmed.com, where a webcast will be hosted. For those preferring to join by phone, U.S. participants can dial 1-800-836-8184, while international listeners should use 1-646-357-8785. When prompted, callers should provide the operator with the conference call name,